Document Type
Patent
Publication Date
2-23-2016
Patent Number
9265783
CPC
A61K 31/7076 (20130101)
Abstract
This application relates to combination therapies including triciribine compounds and epidermal growth factor receptor inhibitor compounds, particularly erlotinib-like compounds and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.
Application Number
14/092,323
Recommended Citation
Cheng, Jin Q. and Sebti, Said M., "Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof" (2016). USF Patents. 835.
https://digitalcommons.usf.edu/usf_patents/835
Assignees
University of South Florida
Filing Date
2013-11-27